s-1743 and Hepatitis--Chronic

s-1743 has been researched along with Hepatitis--Chronic* in 1 studies

Trials

1 trial(s) available for s-1743 and Hepatitis--Chronic

ArticleYear
[Experience of application of Esomeprazole in patients with chronic hepatic diseases associated with acid-dependent diseases].
    Eksperimental'naia i klinicheskaia gastroenterologiia = Experimental & clinical gastroenterology, 2004, Issue:2

    Esomeprazole is efficient for acid-dependent diseases of the gastrointestinal tract in patients with chronic hepatitis and hepatic cirrhosis as it can reduce the disease symptoms and cause the epithelization of erosive and ulcerative defects of the mucous coat. The terms of the cicatrisation of erosive and ulcerative defects of the mucous coat of the esophagus, stomach and duodenum are comparable in patients with liver diseases and in the population (without chronic hepatic diseases). The simultaneous application of Nexium and modern hepatotropic drugs does not cause the development of hepatotoxic reactions.

    Topics: Adolescent; Adult; Aged; Anti-Ulcer Agents; Chronic Disease; Esomeprazole; Female; Gastric Acid; Hepatitis, Chronic; Humans; Liver Cirrhosis; Male; Middle Aged; Peptic Ulcer

2004